[gpfsug-discuss] EXTERNAL: Potential talks for GPFS UG May 20th

Zachary Giles zgiles at gmail.com
Thu Mar 26 16:14:36 GMT 2015


It's at the GPFSUG in the UK. Looks like the UK GPFSUG is much more active
than the US one's. They've had a few meetups actually.
I'd fly out there and attend them, but I figured probably it wouldn't count
since it's not a real conf.
This on is in May 20th.

On Thu, Mar 26, 2015 at 11:56 AM, McLaughlin, Sandra M <
Sandra.McLaughlin at astrazeneca.com> wrote:

>  Life Sciences talk would be spot on for me too, please.
>
>
>
> Sandra McLaughlin
>
>
>
> *From:* gpfsug-discuss-bounces at gpfsug.org [mailto:
> gpfsug-discuss-bounces at gpfsug.org] *On Behalf Of *Mark.Roberts at awe.co.uk
> *Sent:* 26 March 2015 15:24
> *To:* gpfsug-discuss at gpfsug.org
> *Subject:* Re: [gpfsug-discuss] EXTERNAL: Potential talks for GPFS UG May
> 20th
>
>
>
> As well as supporting the efforts of our friends at NERSC I think should
> be a good interesting talk.
>
>
>
> Mark Roberts
>
>
>  ------------------------------
>
> *From:* gpfsug-discuss-bounces at gpfsug.org [
> mailto:gpfsug-discuss-bounces at gpfsug.org
> <gpfsug-discuss-bounces at gpfsug.org>] *On Behalf Of *Ross Keeping3
> *Sent:* 26 March 2015 15:00
> *To:* gpfsug-discuss at gpfsug.org
> *Subject:* EXTERNAL: [gpfsug-discuss] Potential talks for GPFS UG May 20th
>
>
>
> Hi
>
> There are a couple of talks we could include in the one day GPFS UG on May
> 20th.
>
> We'd appreciate some feedback on whether there is any interest or
> objection to including these.
>
> These are:
> 1) Tivoli Storage Productivity Center Technical Demo: A tool for managing
> heterogeneous storage infrastructures and specifically GPFS. Can read more
> here http://www-03.ibm.com/software/products/en/tivostorprodcent
>
> 2) GPFS for life sciences: A member of NERSC would like to talk about
> their efforts to improve GPFS file systems for a life sciences workload -
> specifically genomic sequencing and analysis that ensues. Details about
> life science workflow and requirements will be provided so the listener may
> understand the aspects of GPFS that are important.
>
> Cheers,
> Ross
> Unless stated otherwise above:
> IBM United Kingdom Limited - Registered in England and Wales with number
> 741598.
> Registered office: PO Box 41, North Harbour, Portsmouth, Hampshire PO6 3AU
>
> ___________________________________________________
> ____________________________ The information in this email and in any
> attachment(s) is commercial in confidence. If you are not the named
> addressee(s) or if you receive this email in error then any distribution,
> copying or use of this communication or the information in it is strictly
> prohibited. Please notify us immediately by email at admin.internet(at)
> awe.co.uk, and then delete this message from your computer. While
> attachments are virus checked, AWE plc does not accept any liability in
> respect of any virus which is not detected. AWE Plc Registered in England
> and Wales Registration No 02763902 AWE, Aldermaston, Reading, RG7 4PR
>  ------------------------------
>
> AstraZeneca UK Limited is a company incorporated in England and Wales with
> registered number: 03674842 and a registered office at 2 Kingdom Street,
> London, W2 6BD.
>
> *Confidentiality Notice: *This message is private and may contain
> confidential, proprietary and legally privileged information. If you have
> received this message in error, please notify us and remove it from your
> system and note that you must not copy, distribute or take any action in
> reliance on it. Any unauthorised use or disclosure of the contents of this
> message is not permitted and may be unlawful.
>
> *Disclaimer:* Email messages may be subject to delays, interception,
> non-delivery and unauthorised alterations. Therefore, information expressed
> in this message is not given or endorsed by AstraZeneca UK Limited unless
> otherwise notified by an authorised representative independent of this
> message. No contractual relationship is created by this message by any
> person unless specifically indicated by agreement in writing other than
> email.
>
> *Monitoring: *AstraZeneca UK Limited may monitor email traffic data and
> content for the purposes of the prevention and detection of crime, ensuring
> the security of our computer systems and checking compliance with our Code
> of Conduct and policies.
>
> _______________________________________________
> gpfsug-discuss mailing list
> gpfsug-discuss at gpfsug.org
> http://gpfsug.org/mailman/listinfo/gpfsug-discuss
>
>


-- 
Zach Giles
zgiles at gmail.com
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://gpfsug.org/pipermail/gpfsug-discuss_gpfsug.org/attachments/20150326/48d79ea0/attachment.htm>


More information about the gpfsug-discuss mailing list